Direct and indirect targets of the E2A-PBX1 leukemia-specific fusion protein

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Diakos, Christofer ^a,b   Xiao, Yuanyuan ^a   Zheng, Shichun ^a,c   Kager, Leo ^b   Dworzak, Michael ^b,d   Wiemels, Joseph L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d CHILDREN'S CANCER RESEARCH INSTITUTE   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CYCLE PROTEIN; E2A PBX1 FUSION PROTEIN; HYBRID PROTEIN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; WNT PROTEIN; E2A-PBX1 FUSION PROTEIN; HOMEODOMAIN PROTEIN; ONCOPROTEIN; PROTEIN BINDING;

ARTICLE; BINDING AFFINITY; BINDING SITE; CELL CYCLE REGULATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; MOLECULAR DYNAMICS; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; TREND STUDY; ACUTE LYMPHOBLASTIC LEUKEMIA; CHROMOSOME 9; CHROMOSOME DELETION; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENE TRANSLOCATION; GENETICS; HUMAN; LEUKEMIA; METABOLISM; NUCLEOTIDE MOTIF; POSITION WEIGHT MATRIX; PROMOTER REGION; TUMOR CELL LINE;

BINDING SITES; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 9; GENE EXPRESSION REGULATION, LEUKEMIC; GENE REGULATORY NETWORKS; HOMEODOMAIN PROTEINS; HUMANS; LEUKEMIA; NUCLEOTIDE MOTIFS; ONCOGENE PROTEINS, FUSION; POSITION-SPECIFIC SCORING MATRICES; PRECURSOR B-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; TRANSCRIPTION FACTORS; TRANSLOCATION, GENETIC;

EID: 84895136491     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0087602     Document Type: Article

References (26)

1. Aspland SE, Bendall HH, Murre C (2001) The role of E2A-PBX1 in leukemogenesis. Oncogene 20: 5708-5717. (Pubitemid 32928108)
2. Carroll WL, Bhojwani D, Min DJ, Moskowitz N, Raetz EA (2006) Childhood acute lymphoblastic leukemia in the age of genomics. Pediatr Blood Cancer 46: 570-578.
3. Harrison CJ (2001) The detection and significance of chromosomal abnormalities in childhood acute lymphoblastic leukaemia. Blood Rev 15: 49-59.
4. Bourette RP, Grasset MF, Mouchiroud G (2007) E2a/Pbx1 oncogene inhibits terminal differentiation but not myeloid potential of pro-T cells. Oncogene 26: 234-247. (Pubitemid 46095734)
5. Chang CP, de Vivo I, Cleary ML (1997) The Hox cooperativity motif of the chimeric oncoprotein E2a-Pbx1 is necessary and sufficient for oncogenesis. Mol Cell Biol 17: 81-88.
6. Kamps MP (1997) E2A-Pbx1 induces growth, blocks differentiation, and interacts with other homeodomain proteins regulating normal differentiation. Curr Top Microbiol Immunol 220: 25-43.
7. Monica K, LeBrun DP, Dedera DA, Brown R, Cleary ML (1994) Transformation properties of the E2a-Pbx1 chimeric oncoprotein: fusion with E2a is essential, but the Pbx1 homeodomain is dispensable. Mol Cell Biol 14: 8304-8314. (Pubitemid 24373579)
8. Thorsteinsdottir U, Krosl J, Kroon E, Haman A, Hoang T, et al. (1999) The oncoprotein E2A-Pbx1a collaborates with Hoxa9 to acutely transform primary bone marrow cells. Mol Cell Biol 19: 6355-6366. (Pubitemid 29399340)
9. Casagrande G, te Kronnie G, Basso G (2006) The effects of siRNA-mediated inhibition of E2A-PBX1 on EB-1 and Wnt16b expression in the 697 pre-B leukemia cell line. Haematologica 91: 765-771. (Pubitemid 44014542)
10. Mazieres J, You L, He B, Xu Z, Lee AY, et al. (2005) Inhibition of Wnt16 in human acute lymphoblastoid leukemia cells containing the t(1;19) translocation induces apoptosis. Oncogene 24: 5396-5400. (Pubitemid 43080110)
11. McWhirter JR, Neuteboom ST, Wancewicz EV, Monia BP, Downing JR, et al. (1999) Oncogenic homeodomain transcription factor E2A-Pbx1 activates a novel WNT gene in pre-B acute lymphoblastoid leukemia. Proc Natl Acad Sci U S A 96: 11464-11469. (Pubitemid 29487403)
12. Diakos C, Krapf G, Gerner C, Inthal A, Lemberger C, et al. (2007) RNAi-mediated silencing of TEL/AML1 reveals a heat-shock protein- and survivin-dependent mechanism for survival. Blood 109: 2607-2610. (Pubitemid 46425909)
13. Boeger H, Griesenbeck J, Strattan JS, Kornberg RD (2003) Nucleosomes unfold completely at a transcriptionally active promoter. Molecular cell 11: 1587-1598. (Pubitemid 36776544)
14. Wiencke JK, Zheng S, Morrison Z, Yeh RF (2008) Differentially expressed genes are marked by histone 3 lysine 9 trimethylation in human cancer cells. Oncogene 27: 2412-2421. (Pubitemid 351521100)
15. Thomson JM, Parker J, Perou CM, Hammond SM (2004) A custom microarray platform for analysis of microRNA gene expression. Nat Methods 1: 47-53.
16. Wiemels JL, Leonard BC, Wang Y, Segal MR, Hunger SP, et al. (2002) Site-specific translocation and evidence of postnatal origin of the t(1;19) E2A-PBX1 fusion in childhood acute lymphoblastic leukemia. Proc Natl Acad Sci U S A 99: 15101-15106. (Pubitemid 35334616)
17. Krig SR, Jin VX, Bieda MC, O'Geen H, Yaswen P, et al. (2007) Identification of genes directly regulated by the oncogene ZNF217 using chromatin immunoprecipitation (ChIP)-chip assays. J Biol Chem 282: 9703-9712. (Pubitemid 47104577)
18. Paquette J, Tokuyasu T (2010) EGAN: exploratory gene association networks. Bioinformatics 26: 285-286.
19. van Dijk MA, Peltenburg LT, Murre C (1995) Hox gene products modulate the DNA binding activity of Pbx1 and Pbx2. Mech Dev 52: 99-108.
20. Boeger H, Griesenbeck J, Strattan JS, Kornberg RD (2003) Nucleosomes unfold completely at a transcriptionally active promoter. Mol Cell 11: 1587-1598. (Pubitemid 36776544)
21. Smith KS, Chanda SK, Lingbeek M, Ross DT, Botstein D, et al. (2003) Bmi-1 regulation of INK4A-ARF is a downstream requirement for transformation of hematopoietic progenitors by E2a-Pbx1. Mol Cell 12: 393-400. (Pubitemid 37238926)
22. Maloney KW, McGavran L, Odom LF, Hunger SP (1998) Different patterns of homozygous p16INK4A and p15INK4B deletions in childhood acute lymphoblastic leukemias containing distinct E2A translocations. Leukemia 12: 1417-1421. (Pubitemid 28442389)
23. Ohnishi H, Hanada R, Horibe K, Hongo T, Kawamura M, et al. (1996) Homozygous deletions of p16/MTS1 and p15/MTS2 genes are frequent in t(1;19)-negative but not in t(1;19)-positive B precursor acute lymphoblastic leukemia in childhood. Leukemia 10: 1104-1110. (Pubitemid 26254011)
24. Park C, Han S, Lee KM, Choi JY, Song N, et al. (2012) Association between CASP7 and CASP14 genetic polymorphisms and the risk of childhood leukemia. Hum Immunol 73: 736-739.
25. Lamkanfi M, Kanneganti TD (2010) Caspase-7: a protease involved in apoptosis and inflammation. Int J Biochem Cell Biol 42: 21-24.
26. Kim DH, Xu W, Ma C, Liu X, Siminovitch K, et al. (2009) Genetic variants in the candidate genes of the apoptosis pathway and susceptibility to chronic myeloid leukemia. Blood 113: 2517-2525.